- METTL Family in Health and Disease
Jiejie He et al, 2024, Molecular Biomedicine CrossRef - METTL5: A Potential Biomarker for Nonsmall Cell Lung Cancer That Promotes Cancer Cell Proliferation by Interacting with IGF2BP3
Sihan Gong et al, 2024, Genetic Testing and Molecular Biomarkers CrossRef - Ghost authors revealed: The structure and function of human N6‐methyladenosine RNA methyltransferases
Kurtis Breger et al, 2024, WIREs RNA CrossRef - Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
Qianru Zhu et al, 2022, Frontiers in Genetics CrossRef - N6-methyladenosine modifications in maternal-fetal crosstalk and gestational diseases
Suqi Wu et al, 2023, Frontiers in Cell and Developmental Biology CrossRef - L3MBTL2-mediated CGA transcriptional suppression promotes pancreatic cancer progression through modulating autophagy
Hua Huang et al, 2022, iScience CrossRef - Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan et al, 2024, Cancer Medicine CrossRef - METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression
Zihao Dai et al, 2023, Molecular Therapy CrossRef - The novel m6A writer methyltransferase 5 is a promising prognostic biomarker and associated with immune cell infiltration in oral squamous cell carcinoma
Priyadharshini Muthumanickam et al, 2024, Journal of Oral Pathology & Medicine CrossRef - METTL5 promotes cell proliferation, invasion, and migration by up-regulating Toll-like receptor 8 expression in colorectal cancer
Ling-Shang Kong et al, 2024, World Journal of Gastrointestinal Oncology CrossRef - Reniformin A suppresses non-small cell lung cancer progression by inducing TLR4/NLRP3/caspase-1/GSDMD-dependent pyroptosis
Huiyu Zhu et al, 2024, International Immunopharmacology CrossRef - Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
Hyein Jo et al, 2023, International Journal of Molecular Sciences CrossRef - The Emerging Role of m6A Modification in Endocrine Cancer
Xiaoyu Ji et al, 2023, Cancers CrossRef - Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC)
Hao Chen et al, 2023, Heliyon CrossRef - New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
Wenli Cheng et al, 2022, Frontiers in Pharmacology CrossRef - Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)
Tong Ye et al, 2022, International Journal of Oncology CrossRef - The m6A methylation landscape, molecular characterization and clinical relevance in prostate adenocarcinoma
Chao Li et al, 2023, Frontiers in Immunology CrossRef - METTLing in Stem Cell and Cancer Biology
John G. Tooley et al, 2023, Stem Cell Reviews and Reports CrossRef - The novel m6A writer METTL5 as prognostic biomarker probably associating with the regulation of immune microenvironment in kidney cancer
null Wei Zhang et al, 2022, Heliyon CrossRef - METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation
Chengjie Lin et al, 2023, Cell Death & Disease CrossRef - METTL5 promotes gastric cancer progression via sphingomyelin metabolism
Ya-Qiong Zhang et al, 2024, World Journal of Gastrointestinal Oncology CrossRef - METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
Peng Xia et al, 2023, Cancer Communications CrossRef - Decoding the ribosome's hidden language: rRNA modifications as key players in cancer dynamics and targeted therapies
Li Cui et al, 2024, Clinical and Translational Medicine CrossRef - TFAIP6 facilitates hepatocellular carcinoma cell glycolysis through upregulating c-myc/PKM2 axis
Kecai Duan et al, 2024, Heliyon CrossRef